 | • レポートコード：MRC2303J0162 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、236ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、世界のバイオセンサー市場規模が2021年に271.7億ドル、2022年には303.6億ドルに到達し、今後CAGR 12.13％で成長して2027年までに540.2億ドルまで拡大すると予測しています。当調査資料では、バイオセンサーの世界市場について調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別（組み込みデバイス、センサーパッチ）分析、技術別（電気化学バイオセンサー、ナノメカニカルバイオセンサー、光バイオセンサー、圧電バイオセンサー、熱バイオセンサー）分析、製品別（非ウェアラブルバイオセンサー、ウェアラブルバイオセンサー）分析、産業別（バイオディフェンス、環境モニタリング、食品＆飲料、在宅医療、POC）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目をまとめております。なお、当書に掲載されている企業情報には、Abbott Laboratories Inc.、ACON Laboratories, Inc.、Bayer AG、Bio-Rad Laboratories, Inc.、Biosensors International Group, Ltd.、DuPont de Nemours, Inc.、Ercon Inc.、F. Hoffmann-La Roche AG、GE Healthcare、LifeScan, Inc.、Medtronic PLCなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のバイオセンサー市場規模：種類別 - 組み込みデバイスの市場規模 - センサーパッチの市場規模 ・世界のバイオセンサー市場規模：技術別 - 電気化学バイオセンサーの市場規模 - ナノメカニカルバイオセンサーの市場規模 - 光バイオセンサーの市場規模 - 圧電バイオセンサーの市場規模 - 熱バイオセンサーの市場規模 ・世界のバイオセンサー市場規模：製品別 - 非ウェアラブルバイオセンサーの市場規模 - ウェアラブルバイオセンサーの市場規模 ・世界のバイオセンサー市場規模：産業別 - バイオディフェンスにおける市場規模 - 環境モニタリングにおける市場規模 - 食品＆飲料における市場規模 - 在宅医療における市場規模 - POCにおける市場規模 ・世界のバイオセンサー市場規模：地域別 - 南北アメリカのバイオセンサー市場規模 アメリカのバイオセンサー市場規模 カナダのバイオセンサー市場規模 ブラジルのバイオセンサー市場規模 ... - アジア太平洋のバイオセンサー市場規模 日本のバイオセンサー市場規模 中国のバイオセンサー市場規模 インドのバイオセンサー市場規模 韓国のバイオセンサー市場規模 台湾のバイオセンサー市場規模 ... - ヨーロッパ/中東/アフリカのバイオセンサー市場規模 イギリスのバイオセンサー市場規模 ドイツのバイオセンサー市場規模 フランスのバイオセンサー市場規模 ロシアのバイオセンサー市場規模 ... - その他地域のバイオセンサー市場規模 ・競争状況 ・企業情報 |
The Global Biosensors Market size was estimated at USD 27.17 billion in 2021 and expected to reach USD 30.36 billion in 2022, and is projected to grow at a CAGR 12.13% to reach USD 54.02 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Biosensors to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Embedded Device and Sensor Patch.
Based on Technology, the market was studied across Electrochemical Biosensors, Nanomechanical Biosensors, Optical Biosensors, Piezoelectric Biosensors, and Thermal Biosensors. The Optical Biosensors is further studied across Colorimetric Biosensors, Fluorescence Biosensors, and SPR. The Piezoelectric Biosensors is further studied across Acoustic Biosensors and Microcantilever Biosensors.
Based on Product, the market was studied across Nonwearable Biosensors and Wearable Biosensors. The Wearable Biosensors is further studied across Bodywear, Eyewear, Footwear, Neckwear, and Wristwear.
Based on Industry, the market was studied across Biodefense, Environmental Monitoring, Food & Beverages, Home Diagnostics, POC, and Research Lab. The Home Diagnostics is further studied across Cholesterol Testing Kit, Glucose Monitoring Kit, and Pregnancy Testing Kit. The POC is further studied across Blood Gas & Electrolyte Detection, Cardiac Marker, Cholesterol Testing, Coagulation Monitoring, Glucose Monitoring, Infectious Disease Detection, Pregnancy Testing, Tumor Or Cancer Marker, and Urinalysis Testing.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Biosensors market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biosensors Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biosensors Market, including Abbott Laboratories Inc., ACON Laboratories, Inc., Bayer AG, Bio-Rad Laboratories, Inc., Biosensors International Group, Ltd., DuPont de Nemours, Inc., Ercon Inc., F. Hoffmann-La Roche AG, GE Healthcare, LifeScan, Inc., Medtronic PLC, Nova Biomedical Corporation, Siemens AG, Sysmex Corporation, and Universal Biosensors Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Biosensors Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biosensors Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biosensors Market?
4. What is the competitive strategic window for opportunities in the Global Biosensors Market?
5. What are the technology trends and regulatory frameworks in the Global Biosensors Market?
6. What is the market share of the leading vendors in the Global Biosensors Market?
7. What modes and strategic moves are considered suitable for entering the Global Biosensors Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Emergence of Nanotechnology-Based Biosensors
5.1.1.2. Significant Technological Advancements in Recent Years
5.1.1.3. Growing use of Biosensors to Monitor Glucose Levels in Individuals with Diabetes
5.1.1.4. Rising Demand for Home-Based POC Devices
5.1.1.5. Government Initiatives Toward Diagnostics
5.1.2. Restraints
5.1.2.1. Slow Rate of Commercialization Coupled by Reluctance Toward Adoption of New Treatment Practices
5.1.2.2. High Investment in R&D
5.1.3. Opportunities
5.1.3.1. Growth Opportunities in Developing Countries
5.1.3.2. Increasing Demand in Food Industry, Environmental Monitoring, and Biodefense
5.1.4. Challenges
5.1.4.1. Government Regulations Results in Long Certification and Approval Cycles
5.1.4.2. Pricing pressure in POC market
5.2. Cumulative Impact of COVID-19
6. Biosensors Market, by Type
6.1. Introduction
6.2. Embedded Device
6.3. Sensor Patch
7. Biosensors Market, by Technology
7.1. Introduction
7.2. Electrochemical Biosensors
7.3. Nanomechanical Biosensors
7.4. Optical Biosensors
7.5.1. Colorimetric Biosensors
7.5.2. Fluorescence Biosensors
7.5.3. SPR
7.5. Piezoelectric Biosensors
7.6.1. Acoustic Biosensors
7.6.2. Microcantilever Biosensors
7.6. Thermal Biosensors
8. Biosensors Market, by Product
8.1. Introduction
8.2. Nonwearable Biosensors
8.3. Wearable Biosensors
8.4.1. Bodywear
8.4.2. Eyewear
8.4.3. Footwear
8.4.4. Neckwear
8.4.5. Wristwear
9. Biosensors Market, by Industry
9.1. Introduction
9.2. Biodefense
9.3. Environmental Monitoring
9.4. Food & Beverages
9.5. Home Diagnostics
9.6.1. Cholesterol Testing Kit
9.6.2. Glucose Monitoring Kit
9.6.3. Pregnancy Testing Kit
9.6. POC
9.7.1. Blood Gas & Electrolyte Detection
9.7.2. Cardiac Marker
9.7.3. Cholesterol Testing
9.7.4. Coagulation Monitoring
9.7.5. Glucose Monitoring
9.7.6. Infectious Disease Detection
9.7.7. Pregnancy Testing
9.7.8. Tumor Or Cancer Marker
9.7.9. Urinalysis Testing
9.7. Research Lab
10. Americas Biosensors Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Biosensors Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Biosensors Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbott Laboratories Inc.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. ACON Laboratories, Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Bayer AG
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Bio-Rad Laboratories, Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Biosensors International Group, Ltd.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. DuPont de Nemours, Inc.
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Ercon Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. F. Hoffmann-La Roche AG
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. GE Healthcare
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. LifeScan, Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Medtronic PLC
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Nova Biomedical Corporation
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Siemens AG
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Sysmex Corporation
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Universal Biosensors Inc.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing